John M. Mcpherson , Steven J. Sawamura , Richard A. Condell , Woonza Rhee , Donald G. Wallace
{"title":"肝素对重组胶原理化性质的影响","authors":"John M. Mcpherson , Steven J. Sawamura , Richard A. Condell , Woonza Rhee , Donald G. Wallace","doi":"10.1016/S0174-173X(88)80036-0","DOIUrl":null,"url":null,"abstract":"<div><p>Pepsin-solubilized bovine dermal collagen was reconstituted in 0.02 M sodium phosphate(pH 7.2), concentrated to 30-40 mg/ml, and adjusted to physiological ionic strength by addition of sodium chloride. These preparations, at 4-15 °C, are fibrillar suspensions composed of fibrils of varying diameters and nonassociated molecules. Addition of heparin to these suspensions promoted a dose-dependent increase in average fibril diameter as measured by turbidimetry and electron microscopic analyses. These effects were relatively specific for heparin and heparin-like glycosaminoglycans. Chondroitin sulfate and hyaluronic acid had little or no effect on fibrillar diameters under these conditions, whereas dermatan sulfate had an intermediate effect on fibrillar reorganization. Differential scanning calorimetry revealed that addition of optimal concentrations of heparin generated fibrils of higher stability and that this effect was associated with the disappearance of structures of lower stability, including nonassociated molecules and thin fibrils. Light microscopic analyses of the fibrillar collagen/heparin matrix showed it to be a more open network of distinct collagen fibers than was observed with the fibrillar collagen preparation alone. Binding experiments indicated that heparin bound to fibrillar collagen in a saturable fashion with a Kd of approximately 4 × 10<sup>-7</sup> M. Creep experiments provided evidence that the addition of heparin to fibrillar collagen suspensions greatly reduces the gelation phenomenon that is normally observed when such suspensions are warmed to 37°C. These differences in fibrillar architecture may be in part responsible for differences noted in the biological response to fibrillar collagen and fibrillar collagen/heparin implants <em>in vivo</em> (McPherson et al., 1988).</p></div>","PeriodicalId":77694,"journal":{"name":"Collagen and related research","volume":"8 1","pages":"Pages 65-82"},"PeriodicalIF":0.0000,"publicationDate":"1988-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0174-173X(88)80036-0","citationCount":"53","resultStr":"{\"title\":\"The Effects of Heparin on the Physicochemical Properties of Reconstituted Collagen\",\"authors\":\"John M. Mcpherson , Steven J. Sawamura , Richard A. Condell , Woonza Rhee , Donald G. Wallace\",\"doi\":\"10.1016/S0174-173X(88)80036-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Pepsin-solubilized bovine dermal collagen was reconstituted in 0.02 M sodium phosphate(pH 7.2), concentrated to 30-40 mg/ml, and adjusted to physiological ionic strength by addition of sodium chloride. These preparations, at 4-15 °C, are fibrillar suspensions composed of fibrils of varying diameters and nonassociated molecules. Addition of heparin to these suspensions promoted a dose-dependent increase in average fibril diameter as measured by turbidimetry and electron microscopic analyses. These effects were relatively specific for heparin and heparin-like glycosaminoglycans. Chondroitin sulfate and hyaluronic acid had little or no effect on fibrillar diameters under these conditions, whereas dermatan sulfate had an intermediate effect on fibrillar reorganization. Differential scanning calorimetry revealed that addition of optimal concentrations of heparin generated fibrils of higher stability and that this effect was associated with the disappearance of structures of lower stability, including nonassociated molecules and thin fibrils. Light microscopic analyses of the fibrillar collagen/heparin matrix showed it to be a more open network of distinct collagen fibers than was observed with the fibrillar collagen preparation alone. Binding experiments indicated that heparin bound to fibrillar collagen in a saturable fashion with a Kd of approximately 4 × 10<sup>-7</sup> M. Creep experiments provided evidence that the addition of heparin to fibrillar collagen suspensions greatly reduces the gelation phenomenon that is normally observed when such suspensions are warmed to 37°C. These differences in fibrillar architecture may be in part responsible for differences noted in the biological response to fibrillar collagen and fibrillar collagen/heparin implants <em>in vivo</em> (McPherson et al., 1988).</p></div>\",\"PeriodicalId\":77694,\"journal\":{\"name\":\"Collagen and related research\",\"volume\":\"8 1\",\"pages\":\"Pages 65-82\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1988-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0174-173X(88)80036-0\",\"citationCount\":\"53\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Collagen and related research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0174173X88800360\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Collagen and related research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0174173X88800360","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 53
摘要
在0.02 M磷酸钠(pH 7.2)中重组胃蛋白酶溶解的牛真皮胶原,浓缩至30-40 mg/ml,并通过添加氯化钠调节到生理离子强度。在4-15℃下,这些制剂是由不同直径的原纤维和非相关分子组成的原纤维悬浮液。通过浊度法和电镜分析,在这些悬浮液中加入肝素可以促进平均纤维直径的剂量依赖性增加。这些作用相对特异于肝素和肝素样糖胺聚糖。在这些条件下,硫酸软骨素和透明质酸对纤维直径的影响很小或没有影响,而硫酸皮肤素对纤维重组有中等作用。差示扫描量热法显示,添加最佳浓度的肝素可以生成稳定性更高的原纤维,并且这种效果与稳定性较低的结构(包括非相关分子和薄原纤维)的消失有关。光镜下对纤维胶原/肝素基质的分析表明,与单独的纤维胶原制备相比,它是一个更开放的不同胶原纤维网络。结合实验表明,肝素以饱和的方式与纤维性胶原蛋白结合,Kd约为4 × 10-7 m。蠕变实验证明,在纤维性胶原悬浮液中加入肝素可以大大减少凝胶现象,这种现象通常在纤维性胶原悬浮液加热到37℃时观察到。这些纤维结构上的差异可能是体内对纤维胶原蛋白和纤维胶原/肝素植入物的生物反应差异的部分原因(McPherson et al., 1988)。
The Effects of Heparin on the Physicochemical Properties of Reconstituted Collagen
Pepsin-solubilized bovine dermal collagen was reconstituted in 0.02 M sodium phosphate(pH 7.2), concentrated to 30-40 mg/ml, and adjusted to physiological ionic strength by addition of sodium chloride. These preparations, at 4-15 °C, are fibrillar suspensions composed of fibrils of varying diameters and nonassociated molecules. Addition of heparin to these suspensions promoted a dose-dependent increase in average fibril diameter as measured by turbidimetry and electron microscopic analyses. These effects were relatively specific for heparin and heparin-like glycosaminoglycans. Chondroitin sulfate and hyaluronic acid had little or no effect on fibrillar diameters under these conditions, whereas dermatan sulfate had an intermediate effect on fibrillar reorganization. Differential scanning calorimetry revealed that addition of optimal concentrations of heparin generated fibrils of higher stability and that this effect was associated with the disappearance of structures of lower stability, including nonassociated molecules and thin fibrils. Light microscopic analyses of the fibrillar collagen/heparin matrix showed it to be a more open network of distinct collagen fibers than was observed with the fibrillar collagen preparation alone. Binding experiments indicated that heparin bound to fibrillar collagen in a saturable fashion with a Kd of approximately 4 × 10-7 M. Creep experiments provided evidence that the addition of heparin to fibrillar collagen suspensions greatly reduces the gelation phenomenon that is normally observed when such suspensions are warmed to 37°C. These differences in fibrillar architecture may be in part responsible for differences noted in the biological response to fibrillar collagen and fibrillar collagen/heparin implants in vivo (McPherson et al., 1988).